The Sputum Colour Chart as a predictor of lung inflammation, proteolysis and damage in non-cystic fibrosis bronchiectasis: A case-control analysis

Respirology

Volumn 19, Issue 2, 2014, Pages 203-210

  Goeminne, Pieter C ^a   Vandooren, Jennifer ^b   Moelants, Eva A ^b   Decraene, Ann ^a   Rabaey, Evelyn ^a   Pauwels, Ans ^c   Seys, Sven ^d   Opdenakker, Ghislain ^b   Proost, Paul ^b   Dupont, Lieven J ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

interleukin 8; Leicester Cough Questionnaire; matrix metalloproteinase 9; neutrophil elastase; total gelatinolytic activity

Indexed keywords

ELASTASE; GELATIN; GELATINASE A; GELATINASE B; INTERLEUKIN 8; LEUKOCYTE ELASTASE; MATRIX METALLOPROTEINASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PROTEINASE; TUMOR NECROSIS FACTOR ALPHA; ZINC ION; BIOLOGICAL MARKER;

ADULT; ANALYTICAL EQUIPMENT; ARTICLE; BACTERIAL COLONIZATION; BRONCHIECTASIS; CASE CONTROL STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COUGHING; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LEUKOCYTE DIFFERENTIAL COUNT; LUNG INJURY; MALE; MIDDLE AGED; NEUTROPHIL COUNT; NON CYSTIC FIBROSIS BRONCHIECTASIS; PNEUMONIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PSEUDOMONAS AERUGINOSA; QUESTIONNAIRE; RADIOLOGIST; SCORING SYSTEM; SPIROMETRY; SPUTUM ANALYSIS; SPUTUM COLOR CHART; SPUTUM DISCOLORATION; TOTAL GELATINOLYTIC ACTIVITY; ZYMOGRAPHY; CHEMISTRY; COLOR; COMPLICATION; CYSTIC FIBROSIS; INFLAMMATION; METABOLISM; SPUTUM;

BIOMARKERS; BRONCHIECTASIS; COLOR; CYSTIC FIBROSIS; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PROTEOLYSIS; SPUTUM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84892621825     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12219     Document Type: Article

References (35)

1. Goeminne P, Dupont L,. Non-cystic fibrosis bronchiectasis: diagnosis and management in 21st century. Postgrad. Med. J. 2010; 86: 493-501.
2. Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID,. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 2003; 58: 339-343.
3. Murray MP, Pentland JL, Turnbull K, MacQuarrie S, Hill AT,. Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis. Eur. Respir. J. 2009; 34: 361-364.
4. Fahy JV, Schuster A, Ueki I, Boushey HA, Nadel JA,. Mucus hypersecretion in bronchiectasis. The role of neutrophil proteases. Am. Rev. Respir. Dis. 1992; 146: 1430-1433.
5. Karakoc GB, Inal A, Yilmaz M, Altintas DU, Kendirli SG,. Exhaled breath condensate MMP-9 levels in children with bronchiectasis. Pediatr. Pulmonol. 2009; 44: 1010-1016.
6. Schaaf B, Wieghorst A, Aries SP, Dalhoff K, Braun J,. Neutrophil inflammation and activation in bronchiectasis: comparison with pneumonia and idiopathic pulmonary fibrosis. Respiration 2000; 67: 52-59.
7. Stockley RA, Bayley D, Hill SL, Hill AT, Crooks S, Campbell EJ,. Assessment of airway neutrophils by sputum colour: correlation with airways inflammation. Thorax 2001; 56: 366-372.
8. Tsang KW, Chan K, Ho P, Zheng L, Ooi GC, Ho JC, Lam W,. Sputum elastase in steady-state bronchiectasis. Chest 2000; 117: 420-426.
9. Zheng L, Lam WK, Tipoe GL, Shum IH, Yan C, Leung R, Sun J, Ooi GC, Tsang KW,. Overexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in vivo. Eur. Respir. J. 2002; 20: 170-176.
10. Shum DK, Chan SC, Ip MS,. Neutrophil-mediated degradation of lung proteoglycans: stimulation by tumor necrosis factor-alpha in sputum of patients with bronchiectasis. Am. J. Respir. Crit. Care Med. 2000; 162: 1925-1931.
11. Taggart C, Coakley RJ, Greally P, Canny G, O'Neill SJ, McElvaney NG,. Increased elastase release by CF neutrophils is mediated by tumor necrosis factor-alpha and interleukin-8. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000; 278: L33-L41.
12. Murray MP, Turnbull K, MacQuarrie S, Pentland JL, Hill AT,. Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis. Eur. Respir. J. 2009; 34: 125-131.
13. Lee TW, Brownlee KG, Conway SP, Denton M, Littlewood JM,. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J. Cyst. Fibros. 2003; 2: 29-34.
14. Pizzichini E, Pizzichini MM, Efthimiadis A, Hargreave FE, Dolovich J,. Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination. Eur. Respir. J. 1996; 9: 1174-1180.
15. Truyen E, Coteur L, Dilissen E, Overbergh L, Dupont LJ, Ceuppens JL, Bullens DM,. Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients. Thorax 2006; 61: 202-208.
16. Descamps FJ, Martens E, Opdenakker G,. Analysis of gelatinases in complex biological fluids and tissue extracts. Lab. Invest. 2002; 82: 1607-1608.
17. Abramoff MD, Magalhães PJ, Ram SJ,. Image processing with ImageJ. Biophotonics Int. 2004; 11: 36-42.
18. Vandooren J, Geurt N, Martens E, Van den Steen PE, Jonghe SD, Herdewijn P, Opdenakker G,. Gelatin degradation assay reveals MMP-9 inhibitors and function of O-glycosylated domain. World J. Biol. Chem. 2011; 2: 14-24.
19. Masure S, Proost P, Van Damme J, Opdenakker G,. Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8. Eur. J. Biochem. 1991; 198: 391-398.
20. Moelants EA, Van Damme J, Proost P,. Detection and quantification of citrullinated chemokines. PLoS ONE 2011; 6: e28976.
21. Wuyts A, Struyf S, Gijsbers K, Schutyser E, Put W, Conings R, Lenaerts JP, Geboes K, Opdenakker G, Menten P, et al. The CXC chemokine GCP-2/CXCL6 is predominantly induced in mesenchymal cells by interleukin-1beta and is down-regulated by interferon-gamma: comparison with interleukin-8/CXCL8. Lab. Invest. 2003; 83: 23-34.
22. Van Damme J, Decock B, Conings R, Lenaerts JP, Opdenakker G, Billiau A,. The chemotactic activity for granulocytes produced by virally infected fibroblasts is identical to monocyte-derived interleukin 8. Eur. J. Immunol. 1989; 19: 1189-1194.
23. Brody AS, Klein JS, Molina PL, Quan J, Bean JA, Wilmott RW,. High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests. J. Pediatr. 2004; 145: 32-38.
24. Goeminne PC, Soens J, Scheers H, De Wever W, Dupont L,. Effect of macrolide on lung function and computed tomography (CT) score in non-cystic fibrosis bronchiectasis. Acta Clin. Belg. 2012; 67: 338-346.
25. Jin Q, Huang FH, Zhou Y, Zhang YQ, Chai XJ,. Effect of Pseudomonas aeruginosa on the expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in the airway of bronchiectasis patients. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2012; 34: 384-389.
26. Schaaf B, Liebau C, Kurowski V, Droemann D, Dalhoff K,. Hospital acquired pneumonia with high-risk bacteria is associated with increased pulmonary matrix metalloproteinase activity. BMC Pulm. Med. 2008; 8: 12.
27. Oggioni MR, Memmi G, Maggi T, Chiavolini D, Iannelli F, Pozzi G,. Pneumococcal zinc metalloproteinase ZmpC cleaves human matrix metalloproteinase 9 and is a virulence factor in experimental pneumonia. Mol. Microbiol. 2003; 49: 795-805.
28. Hill SL, Burnett D, Hewetson KA, Stockley RA,. The response of patients with purulent bronchiectasis to antibiotics for four months. Q. J. Med. 1988; 66: 163-173.
29. Jackson PL, Xu X, Wilson L, Weathington NM, Clancy JP, Blalock JE, Gaggar A,. Human neutrophil elastase-mediated cleavage sites of MMP-9 and TIMP-1: implications to cystic fibrosis proteolytic dysfunction. Mol. Med. 2010; 16: 159-166.
30. Stockley RA, Hill SL, Burnett D,. Nebulized amoxicillin in chronic purulent bronchiectasis. Clin. Ther. 1985; 7: 593-599.
31. Mandal P, Sidhu MK, Donaldson LS, Chalmers JD, Smith MP, Turnbull K, Scott J, Hill AT,. Eight-weekly intravenous antibiotics is beneficial in severe bronchiectasis. Q. J. Med. 2013; 106: 27-33.
32. Murray MP, Govan JR, Doherty CJ, Simpson AJ, Wilkinson TS, Chalmers JD, Greening AP, Haslett C, Hill AT,. A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasis. Am. J. Respir. Crit. Care Med. 2011; 183: 491-499.
33. Torrego A, Haque RA, Nguyen LT, Hew M, Carr DH, Wilson R, Chung KF,. Capsaicin cough sensitivity in bronchiectasis. Thorax 2006; 61: 706-709.
34. Polley L, Yaman N, Heaney L, Cardwell C, Murtagh E, Ramsey J, Macmahon J, Costello RW, McGarvey L,. Impact of cough across different chronic respiratory diseases: comparison of two cough-specific health-related quality of life questionnaires. Chest 2008; 134: 295-302.
35. Vandooren J, Geurts N, Martens E, Van den Steen PE, Opdenakker G,. Zymography methods for visualizing hydrolytic enzymes. Nat. Methods 2013; 10: 211-220.